Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank77
3Y CAGR-1.0%
5Y CAGR+10.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.0%/yr
vs +33.3%/yr prior
5Y CAGR
+10.0%/yr
Recent deceleration
Acceleration
-34.4pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $217.49M | -20.4% |
| 2024 | $273.20M | +5.2% |
| 2023 | $259.66M | +15.7% |
| 2022 | $224.34M | +34.1% |
| 2021 | $167.25M | +24.0% |
| 2020 | $134.86M | +77.7% |
| 2019 | $75.90M | +6.9% |
| 2018 | $70.97M | +165.4% |
| 2017 | $26.74M | -36.2% |
| 2016 | $41.88M | - |